SCHEMBL12466150

SCHEMBL12466150

CCOc1c(-c2ccccc2)[nH]c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.50
ESR2 Q92731 1/20 0.50
HTR2A P28223 3/20 0.48
HTR2C P28335 3/20 0.48
DRD2 P14416 1/20 0.47
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46
TUBA1B P68363 1/20 0.46
TUBA4A P68366 1/20 0.46
TUBB4B P68371 1/20 0.46
TUBB3 Q13509 1/20 0.46
TUBB2A Q13885 1/20 0.46
TUBB8 Q3ZCM7 1/20 0.46
TUBA3E Q6PEY2 1/20 0.46
TUBA1A Q71U36 1/20 0.46
TUBA1C Q9BQE3 1/20 0.46
TUBB6 Q9BUF5 1/20 0.46
TUBB2B Q9BVA1 1/20 0.46
TUBB1 Q9H4B7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7133838 0.82 HTR2A (0.57) ESR1ESR2HTR2AHTR2CDRD2
SCHEMBL6826115 0.80 TUBB4A (0.57) ESR1ESR2HTR2AHTR2CTUBB4A
SCHEMBL11790794 0.80 MAPT (0.53) ESR1ESR2HTR2AHTR2CALDH1A1
SCHEMBL3555901 0.80 HTR2A (0.58) ESR1ESR2HTR2AHTR2CDRD2
SCHEMBL7133837 0.78 ESR1 (0.45) ESR1ESR2HTR2AHTR2CDRD2
SCHEMBL27325245 0.77 GABRP (0.46) TUBB3ALDH1A1GABRPGABRDGABRA1
SCHEMBL10774806 0.76 KDM4E (0.52) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL28461532 0.75 ESR1 (0.53) ESR1ESR2HTR2AHTR2CTUBB4A
SCHEMBL2348532 0.74 ALDH1A1 (0.48) ESR1ESR2TUBB4ATUBBTUBA3C
SCHEMBL6995871 0.73 TUBB4A (0.53) ESR1ESR2TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2670244-A2 BICYCLIC AND TRICYCLIC PYRIMIDINE TYROSINE KINASE INHIBITORS WITH ANTITUBULIN ACTIVITY AND METHODS OF TREATING A PATIENT Duquesne University of The Holy Spirit (US) 2013-12-11 EP disclosed
WO-2012106522-A2 BICYCLIC AND TRICYCLIC PYRIMIDINE TYROSINE KINASE INHIBITORS WITH ANTITUBULIN ACTIVITY AND METHODS OF TREATING A PATIENT DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) 2012-08-09 WO disclosed